News
Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...
Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...
A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...
17h
News-Medical.Net on MSNNovel strategy for treating acute myelogenous leukemia identifiedA Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...
Widely used drug could prevent leukaemia among those at risk - People at high risk of acute myeloid leukaemia (AML) can be ...
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...
2dOpinion
MedPage Today on MSNI Survived Leukemia Because of a Clinical Trial. Will Future Patients Be So Lucky?Research doesn't happen by accident. Clinical trials don't appear overnight. Every treatment we use at the bedside starts ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that ...
News Medical on MSN15d
HLA-DRB1 molecule can be a potential target in treating acute myeloid leukemiaHowever, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia (AML). AML patients are often treated using allogeneic hematopoietic stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results